Excelra Named Leader in Everest Group's 2026 Pharmaceutical R&D IT Services Assessment
Excelra, a global life sciences data and informatics company, has been named a Leader in Everest Group's Pharmaceutical R&D IT Services PEAK Matrix Assessment 2026. Among 34 providers evaluated, Excelra was recognized for its combination of curated data, scientific AI, and domain expertise. Its flagship product, GOSTAR, features 37 million bioactivity data points and is designed for AI and machine learning applications. The company’s recent acquisitions have enhanced its scientific consulting capabilities and client proximity, supported by a strong partner ecosystem.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (82/100). Lens Score 33/100.
Outlets measured: thetribune, thehindu. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (78–85/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thehindu broke this story on 4 Nov, 05:00 pm. Other outlets followed.